SVNT

AcronymDefinition
SVNTSerum Virus Neutralization Test
References in periodicals archive ?
Shareholders of US-based oilfield services company Seventy Seven Energy, Inc's (OTC: SVNT) will vote on 20 April 2017 to consider provisions related to the company's agreed deal to be acquired by US-based onshore contract drilling and pressure pumping services company Patterson-UTI Energy, Inc (NASDAQ: PTEN), the company said.
(Nasdaq: SVNT), a specialty biopharmaceutical company, announced yesterday that it has named Louis Ferrari as its president and chief executive officer, effective immediately.
Tickers featured: CGPI, FRX, NGSX, SVNT. Complete text approximately 3000 words.
US-based oilfield services company Seventy Seven Energy, Inc's (OTC: SVNT) shareholders of record as of 22 February will get to vote on the company's pending acquisition by US-based onshore contract drilling and pressure pumping services company Patterson-UTI Energy, Inc (NASDAQ: PTEN), the company said.
Tickers featured: AMGN, DNA, GILD, HTI, LAB:TSX, PANC, PGNX, SVNT, WYE.
23 February 2017 - US-based oilfield services company Seventy Seven Energy, Inc's (OTC: SVNT) shareholders of record as of 22 February will get to vote on the company's pending acquisition by US-based onshore contract drilling and pressure pumping services company Patterson-UTI Energy, Inc (NASDAQ: PTEN), the company said.
US-based onshore contract drilling and pressure pumping services company Patterson-UTI Energy, Inc (NASDAQ: PTEN) and US-based US-based oilfield services company Seventy Seven Energy, Inc (OTC: SVNT) have entered into a definitive merger agreement pursuant to which Patterson-UTI will acquire Seventy Seven Energy in an all-stock transaction, the companies said.
14 December 2016 - US-based onshore contract drilling and pressure pumping services company Patterson-UTI Energy, Inc (NASDAQ: PTEN) and US-based US-based oilfield services company Seventy Seven Energy, Inc (OTC: SVNT) have entered into a definitive merger agreement pursuant to which Patterson-UTI will acquire Seventy Seven Energy in an all-stock transaction, the companies said.
31 May 2011 - US-based biopharmaceutical company Savient Pharmaceuticals Inc (NASDAQ: SVNT) announced last week that the Marketing Authorization Application (MAA), filed by its subsidiary, Savient Pharma Ireland Limited, seeking approval of KRYSTEXXA (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy, has completed validation by the European Medicines Agency (EMA).